preclinical therapeutic development

Ichor Biologics (Ichor) is a NYC-based, pre-clinical biotechnology company that has generated a novel platform for the isolation of naturally-occurring human monoclonal antibodies against infectious diseases. The company aims to accelerate therapeutic development in the infectious disease space by rapidly producing antibody-based therapeutics, and to produce antibody-related intellectual property through the preclinical validation stage for strategic partnerships or licensing deals.

Read more

antibody isolation and characterizationimmunology and infectious disease research